Using a new method, scientists are better able to distinguish between mirror-image substances. This is important amongst others in drug development, because the two variants can cause completely different effects in the human body. Researchers from Paul Scherrer Institute PSI, EPF Lausanne ... more
Prof. Dr. Gérard Hopfgartner
Université de Genève, Life Sciences Mass Spectrometry
Gérard Hopfgartner, studied chemistry at the University of Geneva and received his Ph.D. degree in 1991 in the field of organic geochemistry and mass spectrometry. He pursued his formation as a postdoctoral fellow at Cornell University in the domain of LC-MS/MS atmospheric pressure ionization. Then in 1992 he joined the DMPK Department of F. Hoffmann-La Roche in Basel where he was in charge of the bioanalytical section. Since April 2002 he has been full Professor for analytical sciences and mass spectrometry at the University of Geneva. His scientific interests include the application and the development of novel mass spectrometry approaches with and without chromatography in the field of life sciences in particular, metabolomics, analytical proteomics, Qual-Quant bioanalysis and toxicology.